Jaundice due to glucose-6-phosphate dehydrogenase deficiency

NeoReviews

Volumn 13, Issue 3, 2012, Pages

  Bhutani, Vinod K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861378547     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.13-3-e166     Document Type: Article

References (51)

1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316
2. Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol. 2010;30(suppl):S6-S15
3. Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-3636
4. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67(6):601-611
5. Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev. 1996;10(1):45-52
6. Valaes T, Karaklis A, Stravrakakis D, Bavela-Stravrakakis K, Perakis A, Doxiadis SA. Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res. 1969;3(5):448-458
7. Online Mendelian Inheritance in Man. Glucose-6-phosphate dehydrogenase; G6PD. Available at: http://omim.org/entry/305900. Accessed October 8, 2011
8. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74
9. Bhutani VK, Johnson LH, Jeffrey Maisels M, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24(10):650-662
10. Maisels MJ. Jaundice. In: MacDonald MG, Seshia MMK, Mullett MD, eds. Avery's Neonatology: Pathophysiology and Management of the Newborn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2005:768-846
11. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA. 1997;94 (22):12128-12132
12. Kaplan M, Beutler E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Pediatrics. 1999;104(1 pt 1):68-74
13. Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110(4):e47
14. Kaplan M, Hammerman C. The need for neonatal glucose-6- phosphate dehydrogenase screening: a global perspective. J Perinatol. 2009;29(suppl 1):S46-S52
15. Chinevere TD, Murray CK, Grant E Jr, Johnson GA, Duelm F, Hospenthal DR. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med. 2006;171(9):905-907
16. Beal AC, Chou SC, Palmer RH, et al. Testa MA, Newman C, Ezhuthachan S. The changing face of race: risk factors for neonatal hyperbilirubinemia. Pediatrics. 2006;117(5):1618-1625
17. Herschel M, Beutler E. Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency. Blood Cells Mol Dis. 2001;27(5): 918-923
18. Nock ML, Johnson EM, Krugman RR, et al. Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol. 2011;31(2):112-117
19. AlOtaibi SF, Blaser S, MacGregor DL. Neurological complications of kernicterus. Can J Neurol Sci. 2005;32(3):311-315
20. Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol. 1992;87(1-2):29-31
21. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr. 1991;119(2):293-299
22. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-278
23. Padilla CD, Therrell BL. Newborn screening in the Asia Pacific region. J Inherit Metab Dis. 2007;30(4):490-506
24. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to2004). J Perinatol. 2009;29(suppl 1):S25-S45
25. Zangen SD, Kidron D, Gelbart T, Roy-Chowdhury N, Wang X, Kaplan M. Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity. J Pediatr. 2009;154(4):616-619
26. Watchko JF. Hyperbilirubinemia in African American neonates: clinical issues and current challenges. Semin Fetal Neonatal Med. 2010;15(3):176-182
27. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6): 587-590
28. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed. 2006:92(5):F342-F346
29. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001; 108(1):31-39
30. Bhutani VK, Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol. 2006;30(2): 89-97
31. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991;324(3):169-174
32. Spolarics Z, Siddiqi M, Siegel JH, et al. Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med. 2001;29(4): 728-736
33. Wilmanski J, Siddiqi M, Deitch EA, Spolarics Z. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages. J Leukoc Biol. 2005;78(1):85-94
34. Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989;114(5):748-752
35. Schutzman DL, Porat R. Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis? J Pediatr. 2007;151(4):435-437
36. Murki S, Dutta S. Onset of bilirubin rise in G6PD deficient neonates prenatal or postnatal. Indian Pediatr. 2005;42(10):1053
37. Kaplan M, Hammerman C. Onset of jaundice in G6PD deficient neonates. Indian Pediatr. 2006;43(5):459-461
38. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004; 114(2):e213-e219
39. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Heller GZ, Stevenson DK. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 2006;149(1):83-88
40. Monaghan G, McLellan A, McGeehan A, et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr. 1999;134(4):441-446
41. Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A. Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn. Pediatr Int. 2010;52(5):769-772
42. Bartlett MG, Gourley GR. Assessment of UGT polymorphisms and neonatal jaundice. Semin Perinatol. 2011;35(3):127-133
43. Gourley GR, Li Z, Kreamer BL, Kosorok MR. A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics. 2005;116(2):385-391
44. Kaplan M. Data presented at the US Stakeholders Conference to Determine the feasibility of G6PD deficiency identification for prevention of severe neonatal hyperbilirubinemia; July 29, 2009; Bethesda, MD
45. Mallouh AA, Imseeh G, Abu-Osba YK, Hamdan JA. Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Ann Trop Paediatr. 1992;12(4):391-395
46. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. Pediatrics. 2009;124 (4):1193-1198
47. American Academy Pediatrics, Committee on Fetus And Newborn. Technical report: Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant ≥35 weeks of gestation. Pediatrics. 2011;128(4):e1046-e1052
48. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920-928
49. Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol. 2011;35(3): 175-184
50. Kappas A, Drummond GS, Valaes T. A single dose of Snmesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics. 2001;108(1):25-30
51. Wang FL, Boo NY, Ainoon O, Wong MK. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia. Singapore Med J. 2009;50(1):62-67